reports
Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data fr...
Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025 Data showed improvements across several key measures of visual function, including low luminance visual acuity and microperimetry Laru-zova was generally well-tolerated by DAWN participants at 6 months LONDON and CAMBRIDGE, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and restore the ...
Syncona Limited Portfolio Company Successfully Completes Tender Offer ...
Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful completion of the previously announced tender offer (the “Offer”) to purchase all of the issued and outstanding shares of common stock of AGTC by a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”). The Offer, as extended, expired at 5:00 p.m., Eastern Time, on Nove...
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Appl...
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”) has extended the expiration of its previously announced tender offer to purchase all of the issued and outstanding shares of AGTC common stock for $0.34 per share in cash at closing, plus up to an additional $0.73 per share payable pursuant to con...
*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by Nov...
*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER* GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achievement ...
- David Nierengarten
- Dennis Pak
*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November ...
*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *REMINDER* GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achievement of specifi...
- Wedbush Research
- David Nierengarten
- Dennis Pak
Applied Genetic Technologies Corporation Urges Shareholders to Tender ...
Applied Genetic Technologies Corporation Urges Shareholders to Tender Their Shares by November 28, 2022 GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, sent the following letter to stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share u...
Applied Genetic Technologies Corporation Reminds Shareholders to Tende...
Applied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022 GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, sent the following letter to shareholders: On October 23, 2022, we announced that AGTC entered into a definitive agreement, pursuant to which a portfolio company of Syncona Limited has commenced a tender offer to purchase all of the outstanding shares of common stock of AGTC. Syncona is a leading, well-...
Syncona Commences Tender Offer for All Outstanding Shares of Applied G...
Syncona Commences Tender Offer for All Outstanding Shares of Applied Genetic Technologies Corporation GAINESVILLE, Fla. and CAMBRIDGE, Mass. and LONDON, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC” or the “Company”) and a newly established portfolio company of Syncona Limited (“Syncona”), a leading healthcare company focused on founding, building and funding global leaders in life science, announced the commencement today of the previously announced tender offer for all of the issued and outstanding shares of common stock of AGTC at a p...
- David Nierengarten
- Dennis Pak
Syncona to Acquire Applied Genetic Technologies Corporation
Syncona to Acquire Applied Genetic Technologies Corporation Upfront consideration in cash of $0.34 per share representing a premium of approximately 42% over AGTC’s closing stock price on October 21, 2022 Total consideration of up to $1.07, including up to $0.73 per CVR, representing a premium of up to approximately 344% over AGTC’s closing stock price on October 21, 2022 AGTC’s Board has examined all alternative options for the future of AGTC and believes this transaction clearly delivers the best value for shareholders Given the state of equity and other funding marke...
- Wedbush Research
MTB M&T BANK CORPORATION
VMW VMWARE INC. CLASS A
INFY INFOSYS LIMITED
SIVB SVB FINANCIAL GROUP
USB U.S. BANCORP
ACN ACCENTURE PLC CLASS A
ZION ZIONS BANCORPORATION N.A.
WTFC WINTRUST FINANCIAL CORPORATION
W9N WNS (HOLDINGS) LIMITED SPONSORED ADR
WDC WESTERN DIGITAL CORPORATION
WBS WEBSTER FINANCIAL CORPORATION
WAL WESTERN ALLIANCE BANCORP
VLY VALLEY NATIONAL BANCORP
UMPQ UMPQUA HOLDINGS CORPORATION
TCBI TEXAS CAPITAL BANCSHARES INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SBNY SIGNATURE BANK
RF REGIONS FINANCIAL CORPORATION
PSTG PURE STORAGE INC. CLASS A
PPBI PACIFIC PREMIER BANCORP INC.
PB PROSPERITY BANCSHARES INC.(R)
PACW PACWEST BANCORP
NYCB NEW YORK COMMUNITY BANCORP INC.
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
KEY KEYCORP
INTC INTEL CORPORATION
HMST HOMESTREET INC.
HBAN HUNTINGTON BANCSHARES INCORPORATED
HAFC HANMI FINANCIAL CORPORATION
35G GENPACT LIMITED
FRC FIRST REPUBLIC BANK
FITB FIFTH THIRD BANCORP
FHN FIRST HORIZON CORPORATION
FFWM FIRST FOUNDATION
FBC FLAGSTAR BANCORP INC.
EXLS EXLSERVICE HOLDINGS INC.
EWBC EAST WEST BANCORP INC.
EPAM EPAM SYSTEMS INC.
CVBF CVB FINANCIAL CORP.
CUBI CUSTOMERS BANCORP INC.
CFG CITIZENS FINANCIAL GROUP INC.
CATY CATHAY GENERAL BANCORP
BKU BANKUNITED INC.
BIIB BIOGEN INC.
AXTI AXT INC.
AGTC APPLIED GENETIC TECHNOLOGIES
WIPRO WIPRO LIMITED
CFR CULLEN/FROST BANKERS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
BOKF BOK FINANCIAL CORPORATION
CMA COMERICA INCORPORATED
GLOB GLOBANT SA
SLM SLM CORP
TSC TRISTATE CAPITAL HOLDINGS INC
HPE HEWLETT PACKARD ENTERPRISE CO.
HOPE HOPE BANCORP INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
AVGO BROADCOM INC.
AX AXOS FINANCIAL INC.
DAVA ENDAVA PLC ADS
DELL DELL TECHNOLOGIES INC CLASS C
LC LENDINGCLUB CORP
AQST AQUESTIVE THERAPEUTICS
SI SILVERGATE CAPITAL
TWKS THOUGHTWORKS HOLDING
MRVL MARVELL TECHNOLOGY INC
STX SEAGATE TECHNOLOGY HLDGS PLC
PAY PAYMENTUS HLDGS INC
MQ MARQETA INC
GFS GLOBALFOUNDRIES INC
- David Nierengarten
- Dennis Pak
- David Nierengarten
- Dennis Pak
SGMO SANGAMO THERAPEUTICS INC.
RGNX REGENXBIO INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
FATE FATE THERAPEUTICS INC
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AGTC APPLIED GENETIC TECHNOLOGIES
NTLA INTELLIA THERAPEUTICS INC.
AVRO AVROBIO
MGTA MAGENTA THERAPEUTICS
ISEE IVERIC BIO
STOK STOKE THERAPEUTICS
PASG PASSAGE BIO
FRLN FREELINE THERAPEUTICS HOLDINGS ADS
CDAK CODIAK BIOSCIENCES
BEAM INC.
GBIO BEAM THERAPEUTICS
TSVT GENERATION BIO
TCRR 2SEVENTY BIO INC
TCR2 THERAPEUTICS INC
AGTC to Participate in Upcoming Investor Conferences
AGTC to Participate in Upcoming Investor Conferences GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the development and potential commercialization of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, today announced that management will be participating in the following investor conferences: Wells Fargo Healthcare Conference...
AGTC to Participate in Upcoming Investor Conferences
AGTC to Participate in Upcoming Investor Conferences GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the development and potential commercialization of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, today announced that management will be participating in the following investor conferences: BTIG Biotechnology Conference – New...
AGTC Receives Positive Type C Meeting Feedback from the FDA for the Co...
AGTC Receives Positive Type C Meeting Feedback from the FDA for the Company’s Design and Operating Procedures of its Planned cGMP Manufacturing Facility — FDA feedback marks a key milestone in the construction of the facility expected to support AGTC’s pipeline, including the late-stage development and potential commercialization of AGTC’s X-Linked Retinitis Pigmentosa (XLRP) and Achromatopsia B3 (ACHMB3) programs — GAINESVILLE, Fla. and CAMBRIDGE, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical-stage biotechnology company focu...
- Wedbush Research
2454 MEDIATEK INC.
UBI UBISOFT ENTERTAINMENT SA
VMW VMWARE INC. CLASS A
INFY INFOSYS LIMITED
QRVO QORVO INC.
KMX CARMAX INC.
NCR NCR CORPORATION
ACN ACCENTURE PLC CLASS A
WSM WILLIAMS-SONOMA INC.
W9N WNS (HOLDINGS) LIMITED SPONSORED ADR
WDC WESTERN DIGITAL CORPORATION
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
ORCL ORACLE CORPORATION
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
35G GENPACT LIMITED
EXLS EXLSERVICE HOLDINGS INC.
EPAM EPAM SYSTEMS INC.
DBD DIEBOLD NIXDORF INCORPORATED
CTSH COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION CLASS A
BIIB BIOGEN INC.
AXTI AXT INC.
AGTC APPLIED GENETIC TECHNOLOGIES
MRVL MARVELL TECHNOLOGY GROUP LTD.
WIPRO WIPRO LIMITED
SWKS SKYWORKS SOLUTIONS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
BBBY BED BATH & BEYOND INC.
GLOB GLOBANT SA
HPE HEWLETT PACKARD ENTERPRISE CO.
ARGX ARGENX ADS
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
AVGO BROADCOM INC.
DAVA ENDAVA PLC ADS
RH RESTORATION HARDWARE INC.
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
TWKS THOUGHTWORKS HOLDING
STX SEAGATE TECHNOLOGY HLDGS PLC
TCRR TCR2 THERAPEUTICS INC
GFS GLOBALFOUNDRIES INC
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.